Cyproheptadine Hydrochloride Tablet
Product Images NDC 64380-795

2 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 64380-795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (565b0616 2643 486b 9e4f F030e27bfd4a 01)

Structure (565b0616 2643 486b 9e4f F030e27bfd4a 01)
Chemical structure of Cyproheptadine Hydrochloride showing its molecular framework including fused rings and a piperidine ring with a methyl group attached to the nitrogen atom.*
FDA Label Image

100s Container Label (565b0616 2643 486b 9e4f F030e27bfd4a 02)

100s Container Label (565b0616 2643 486b 9e4f F030e27bfd4a 02)
Label for Cyproheptadine HCl Tablets USP, 4 mg, from Strides Pharma Inc. The label includes dosage information, storage instructions (20° to 25°C), child-resistant container requirement, and warnings to keep out of reach of children. It indicates a package of 100 tablets, Rx only, manufactured by Strides Shasun Limited, India, and distributed by Strides Pharma Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.